FiercePharmaAsia—Takeda’s $2.3B Japan consumer health sale; Bayer’s new Beijing plant; Celltrion’s latest biosim pact chelfand Fri, 08/28/2020 – […]
Category: Uncategorized
The studies aim to increase understanding on immune responses to SARS-CoV-2
NICE says the combination’s cost-effectiveness estimate is higher than what is considered acceptable for NHS use
FoundationOne Liquid CDx analyses more than 300 cancer-related genes and multiple genomic signatures to help inform treatment decisions […]
A survey by GSK Consumer Healthcare and Ipsos MORI also signals a shift towards self-education and reducing the […]
Since autumn 2019, the Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF-funded ERA-NET project “NExT” that aims […]
The novel STAR assay can rapidly determine telomere dysregulation in cancers and age-related diseases in clinical settings.
An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight […]
A new study looked at how pharmacogenomics could improve the safety and effectiveness of COVID-19 drug therapies.
